Viridian Therapeutics, Inc.\de (VRDN)

Last Year

22-Nov-23 -- 21-Nov-24

Time Period:

$616.31K Net Amount

Buy:	$616.31K	$23.33 - $23.41
Sell:	0	--

Company Sentiment

Medical Laboratories & Research

Health Services

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

1

+1

0

+2

2

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
30-Sep-24 7:10 PM View:	27-Sep-24 Market Purchase $499.26K	Mahoney Stephen F. President and CEO Director	$Insider Trading Sentiment for Mahoney Stephen F. at Viridian Therapeutics, Inc.\de (VRDN):$	Viridian Therapeutics, Inc.\de - VRDN	100% 0 to 21.4K	$499.26K 100%	0	$23.33	--	Show Txns Hide Txns

30-Sep-24 7:12 PM View:	27-Sep-24 Market Purchase $117.05K	Beetham Thomas W. Chief Operating Officer	$Insider Trading Sentiment for Beetham Thomas W. at Viridian Therapeutics, Inc.\de (VRDN):$	Viridian Therapeutics, Inc.\de - VRDN	500% 1.0K to 6.0K	$117.05K 500%	0	$23.41	--	Show Txns Hide Txns

17-Sep-24 9:00 PM View:	13-Sep-24 Private Purchase $30.00M	Fairmount Funds Management ... Director 10% Owner	$Insider Trading Sentiment for Fairmount Funds Management LLC at Viridian Therapeutics, Inc.\de (VRDN):$	Viridian Therapeutics, Inc.\de - VRDN	152% 1.37M to 3.45M	0	0	--	--	Show Txns Hide Txns